ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Mydecine Innovations, NeuroPharm Sign Acquisition Agreement americanpharmaceuticalreview
July 22, 2020Mydecine Innovations has entered into a definitive share exchange agreement for the acquisition of 100% of NeuroPharm, a Canadian-based developer of natural psychedelic-based treatments for mental health disorders in the Canadian and United States ...
Pharma Sources Insight January 2025
